Finetti P - Search Results

1

SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer.

Rapetti-Mauss R, Nigri J, Berenguier C, Finetti P, Tubiana SS, Labrum B, Allegrini B, Pellissier B, Efthymiou G, Hussain Z, Bousquet C, Dusetti N, Bertucci F, Guizouarn H, Melnyk P, Borgese F, Tomasini R, Soriani O. Rapetti-Mauss R, et al. Among authors: finetti p. Gut. 2023 Apr;72(4):722-735. doi: 10.1136/gutjnl-2021-326610. Epub 2022 Sep 1. Gut. 2023. PMID: 36882214

2

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Cervera N, Tarpin C, Nguyen C, Xerri L, Houlgatte R, Jacquemier J, Viens P, Birnbaum D. Bertucci F, et al. Among authors: finetti p. Cancer Res. 2005 Mar 15;65(6):2170-8. doi: 10.1158/0008-5472.CAN-04-4115. Cancer Res. 2005. PMID: 15781628

3

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adélaïde J, Debono S, Houvenaeghel G, Maraninchi D, Viens P, Charpin C, Jacquemier J, Birnbaum D. Bertucci F, et al. Among authors: finetti p. Cancer Res. 2006 May 1;66(9):4636-44. doi: 10.1158/0008-5472.CAN-06-0031. Cancer Res. 2006. PMID: 16651414

4

Gene expression profiling and clinical outcome in breast cancer.

Bertucci F, Finetti P, Cervera N, Maraninchi D, Viens P, Birnbaum D. Bertucci F, et al. Among authors: finetti p. OMICS. 2006 Winter;10(4):429-43. doi: 10.1089/omi.2006.10.429. OMICS. 2006. PMID: 17233555 Review.

5

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.

Ginestier C, Adélaïde J, Gonçalvès A, Repellini L, Sircoulomb F, Letessier A, Finetti P, Geneix J, Charafe-Jauffret E, Bertucci F, Jacquemier J, Viens P, Birnbaum D. Ginestier C, et al. Among authors: finetti p. Oncogene. 2007 Nov 1;26(50):7163-9. doi: 10.1038/sj.onc.1210528. Epub 2007 May 21. Oncogene. 2007. PMID: 17525746

6

Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.

Bertucci F, Pages C, Finetti P, Rochaix P, Lamant L, Devilard E, Nguyen C, Houlgatte R, Birnbaum D, Xerri L, Brousset P. Bertucci F, et al. Among authors: finetti p. Anticancer Res. 2007 Sep-Oct;27(5A):3441-9. Anticancer Res. 2007. PMID: 17970093 Free article.

7

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

Finetti P, Cervera N, Charafe-Jauffret E, Chabannon C, Charpin C, Chaffanet M, Jacquemier J, Viens P, Birnbaum D, Bertucci F. Finetti P, et al. Cancer Res. 2008 Feb 1;68(3):767-76. doi: 10.1158/0008-5472.CAN-07-5516. Cancer Res. 2008. PMID: 18245477

8

How basal are triple-negative breast cancers?

Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, Birnbaum D. Bertucci F, et al. Among authors: finetti p. Int J Cancer. 2008 Jul 1;123(1):236-40. doi: 10.1002/ijc.23518. Int J Cancer. 2008. PMID: 18398844

9

[Prognostic classification of breast cancer and gene expression profiling].

Bertucci F, Finetti P, Cervera N, Birnbaum D. Bertucci F, et al. Among authors: finetti p. Med Sci (Paris). 2008 Jun-Jul;24(6-7):599-606. doi: 10.1051/medsci/20082467599. Med Sci (Paris). 2008. PMID: 18601877 Free article. Review. French.

10

How different are luminal A and basal breast cancers?

Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Buttarelli M, Jacquemier J, Chaffanet M, Maraninchi D, Viens P, Birnbaum D. Bertucci F, et al. Among authors: finetti p. Int J Cancer. 2009 Mar 15;124(6):1338-48. doi: 10.1002/ijc.24055. Int J Cancer. 2009. PMID: 19058218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters